Approval · Notice of Compliance 20065 · 2017
MYFORTIC: Notice of Compliance 20065
Issued November 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20065
- Date
- November 20, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new Drug Product Manufacturing Site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYFORTIC | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE SODIUM 180 MG per TAB
- MYCOPHENOLATE SODIUM 360 MG per TAB